The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Itching to find a diagnosis
Open accessAbstract
Answer questions and earn CME Content available: Audio Recording
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since the first report, a total of 14 cases (excluding the current series) of ashwagandha-induced liver injury are available.17–26”
From Ashwagandha-induced liver injury—A case series from India and literature review (2023) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reports of ashwagandha-induced liver injury have been notable in medical literature since 2017.”
From Ashwagandha-induced liver injury—A case series from India and literature review (2023) · cites this paper as [22]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
Björnsson, H. K., Björnsson, E. S., Avula, B., Khan, I. A., Jonasson, J. G., Ghabril, M., Hayashi, P. H., & Navarro, V. (2020) · Liver International · doi:10.1111/liv.14393 · Cited by 125
Research works printed but not linked: 7
- 2016, LiverTox: learn how medications and supplements impact liver health, NLM Technical Bulletin, 410
- 2014, Hepatic histological findings in suspected drug‐induced liver injury: systematic evaluation and clinical associations, Hepatology, 59, 661, 10.1002/hep.26709 · DOI · Paper page
- 2020, Ashwagandha as a cause for liver injury, Liver Int, 40, 2035, 10.1111/liv.14551 · DOI
- 2021, Ashwagandha‐induced liver injury: self‐reports on commercial websites as useful adjunct tools for causality assessment, Am J Gastroenterol, 116, 2151, 10.14309/ajg.0000000000001369 · DOI · Paper page
- 2021, DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of Withania somnifera (Ashwagandha), Curr Res Toxicol, 2, 72, 10.1016/j.crtox.2021.02.002 · DOI · Paper page
- 2016, Beneficial effect of corticosteroids for patients with severe drug‐induced liver injury, J Dig Dis, 17, 618, 10.1111/1751-2980.12383 · DOI · Paper page
- 2009, Intravenous N‐acetylcysteine improves transplant‐free survival in early stage non‐acetaminophen acute liver failure, Gastroenterology, 137, 856, 10.1053/j.gastro.2009.06.006 · DOI · Paper page
Cited by
Sorted by citations
Ashwagandha-induced liver injury—A case series from India and literature review
Philips, C. A., Valsan, A., Theruvath, A. H., Ravindran, R., Oommen, T. T., Rajesh, S., Bishnu, S., Augustine, P., & India, O. B. O. T. L. R. C. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000270 · Cited by 62
Metadata
- Authors
- Patel, A. D., Pinsker, B. L., Wall, A., Arbogast, M., King, L. Y., & Sherzoy, S.
- Affiliations
- Duke University (US)
- Corresponding author
- Patel, Akash D.
- Venue
- Clinical Liver Disease
- Published
- 2022-07-16
- Volume
- 20
- Issue
- 3
- Pages
- 77-80
- ISSN
- 2046-2484 (ISSN-L)
- PMC
- PMC9512456
- OpenAlex
- W4285588764
- Cited by
- 4
- References
- 3
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2022: 1
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Clinical Liver Disease (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- pruritus, liver disease, diagnosis, cholestatic pruritus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
